{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:25:36Z","timestamp":1772119536955,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K12213"],"award-info":[{"award-number":["24K12213"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K22775"],"award-info":[{"award-number":["20K22775"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23H03015"],"award-info":[{"award-number":["23H03015"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-025-04023-w","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T07:11:41Z","timestamp":1766041901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Distinct impact of RNF213 p.R4810K genotype on transdural collateral formation across Japanese Asian and Polish Caucasian Moyamoya patients"],"prefix":"10.1007","volume":"49","author":[{"given":"Dariusz","family":"Szarek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8032-7198","authenticated-orcid":false,"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6567-8136","authenticated-orcid":false,"given":"Haruto","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Lubkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-2585","authenticated-orcid":false,"given":"Kikutaro","family":"Tokairin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0991-0516","authenticated-orcid":false,"given":"Miki","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"issue":"3","key":"4023_CR1","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","volume":"20","author":"J Suzuki","year":"1969","unstructured":"Suzuki J, Takaku A (1969) Cerebrovascular moyamoya disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20(3):288\u2013299. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012","journal-title":"Arch Neurol"},{"issue":"7","key":"4023_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2176\/jns-nmc.2022-0072","volume":"62","author":"S Kuroda","year":"2022","unstructured":"Kuroda S, Fujimura M, Takahashi JC, Kataoka H, Ogasawara K, Iwama T, Tominaga T, Miyamoto S, Research Committee on Moyamoya Disease (Spontaneous Occlusion of Circle of Willis) of the Ministry of Health, Labor, and Welfare, Japan (2022) Diagnostic criteria for Moyamoya disease - 2021 revised version. Neurol Med Chir (Tokyo) 62(7):307\u2013312. https:\/\/doi.org\/10.2176\/jns-nmc.2022-0072","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"1","key":"4023_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1534\/g3.115.020321","volume":"6","author":"LD Shoemaker","year":"2015","unstructured":"Shoemaker LD, Clark MJ, Patwardhan A, Chandratillake G, Garcia S, Chen R, Morgan AA, Leng N, Kirk S, Chen R, Cook DJ, Snyder M, Steinberg GK (2015) Disease variant landscape of a large multiethnic population of Moyamoya patients by exome sequencing. G3 (Bethesda) 6(1):41\u201349. https:\/\/doi.org\/10.1534\/g3.115.020321","journal-title":"G3 (Bethesda)"},{"issue":"8","key":"4023_CR4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","volume":"21","author":"M Ihara","year":"2022","unstructured":"Ihara M, Yamamoto N, Hattori Y, Liu W, Kobayashi H, Ishiyama H, Yoshimoto T, Miyawaki S, Clausen T, Bang OY, Steinberg GK, Tournier-Lasserve E, Koizumi A (2022) Moyamoya disease: diagnosis and interventions. Lancet Neurol 21(8):747\u2013758. https:\/\/doi.org\/10.1016\/S1474-4422(22)00165-X","journal-title":"Lancet Neurol"},{"issue":"12","key":"4023_CR5","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER (2009) Moyamoya disease and Moyamoya syndrome. N Engl J Med 360(12):1226\u20131237. https:\/\/doi.org\/10.1056\/NEJMra0804622","journal-title":"N Engl J Med"},{"issue":"1","key":"4023_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/jhg.2010.132","volume":"56","author":"F Kamada","year":"2011","unstructured":"Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, Owada Y, Fujimura M, Mashimo Y, Suzuki Y, Hata A, Tsuchiya S, Tominaga T, Matsubara Y, Kure S (2011) A genome-wide association study identifies RNF213 as the first Moyamoya disease gene. J Hum Genet 56(1):34\u201340. https:\/\/doi.org\/10.1038\/jhg.2010.132","journal-title":"J Hum Genet"},{"key":"4023_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0022542","volume":"6","author":"W Liu","year":"2011","unstructured":"Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, Hashikata H, Matsuura N, Yamazaki S, Toyoda A, Kikuta K, Takagi Y, Harada KH, Fujiyama A, Herzig R, Krischek B, Zou L, Kim JE, Kitakaze M, Miyamoto S, Nagata K, Hashimoto N, Koizumi A (2011) Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE 6:e22542. https:\/\/doi.org\/10.1371\/journal.pone.0022542","journal-title":"PLoS ONE"},{"issue":"11","key":"4023_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","volume":"78","author":"S Miyatake","year":"2012","unstructured":"Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, Tsurusaki Y, Doi H, Sakai H, Saitsu H, Shimojima K, Yamamoto T, Higurashi M, Kawahara N, Kawauchi H, Nagasaka K, Okamoto N, Mori T, Koyano S, Kuroiwa Y, Taguri M, Morita S, Matsubara Y, Kure S, Matsumoto N (2012) <article-title update=\"modified\" original=\"Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease\"> Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology 78(11):803\u2013810. https:\/\/doi.org\/10.1212\/WNL.0b013e318249f71f","journal-title":"Neurology"},{"key":"4023_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ene.14184","volume":"27","author":"P Ge","year":"2020","unstructured":"Ge P, Zhang Q, Ye X, Liu X, Deng X, Wang J, Wang R, Zhang Y, Zhang D, Zhao J (2020) Angiographic characteristics in Moyamoya disease with the p. R4810K variant: a propensity score-matched analysis. Eur J Neurol 27:856\u2013863. https:\/\/doi.org\/10.1111\/ene.14184","journal-title":"Eur J Neurol"},{"issue":"3","key":"4023_CR10","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s10143-022-01749-9","volume":"45","author":"M Ito","year":"2022","unstructured":"Ito M, Kawabori M, Sugiyama T, Tokairin K, Tatezawa R, Uchino H, Kazumata K, Houkin K, Fujimura M (2022) Impact of RNF213 founder polymorphism (p. R4810K) on the postoperative development of indirect pial synangiosis after direct\/indirect combined revascularization surgery for adult Moyamoya disease. Neurosurg Rev 45(3):2305\u20132313. https:\/\/doi.org\/10.1007\/s10143-022-01749-9","journal-title":"Neurosurg Rev"},{"issue":"2","key":"4023_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000526089","volume":"52","author":"M Kawabori","year":"2023","unstructured":"Kawabori M, Ito M, Kazumata K, Tokairin K, Hatanaka KC, Ishikawa S, Houkin K, Fujimura M (2023) Impact of RNF213 c.14576G>A variant on the development of direct and indirect revascularization in pediatric Moyamoya disease. Cerebrovasc Dis 52(2):171\u2013176. https:\/\/doi.org\/10.1159\/000526089","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"4023_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-024-03165-7","volume":"48","author":"M Mizushima","year":"2024","unstructured":"Mizushima M, Ito M, Uchino H, Sugiyama T, Fujimura M (2024) Impact of RNF213 p. R4810K variant on postoperative temporal muscle swelling used in encephalo-myo-synangiosis after combined revascularization for Moyamoya disease. Neurosurg Rev 48(1):15. https:\/\/doi.org\/10.1007\/s10143-024-03165-7","journal-title":"Neurosurg Rev"},{"issue":"5","key":"4023_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1159\/000528055","volume":"52","author":"SR Unda","year":"2023","unstructured":"Unda SR, Antoniazzi AM, Fluss R, Yassari N, Esenwa C, Haranhalli N, Altschul DJ (2023) Ethnic-associated phenotype variations in Moyamoya cerebrovascular outcomes. Cerebrovasc Dis 52(5):519\u2013525. https:\/\/doi.org\/10.1159\/000528055","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"4023_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/neuros\/nyy236","volume":"85","author":"S Hori","year":"2019","unstructured":"Hori S, Kashiwazaki D, Yamamoto S, Acker G, Czabanka M, Akioka N, Kuwayama N, Vajkoczy P, Kuroda S (2019) Impact of interethnic difference of collateral angioarchitectures on prevalence of hemorrhagic stroke in Moyamoya disease. Neurosurgery 85(1):134\u2013146. https:\/\/doi.org\/10.1093\/neuros\/nyy236","journal-title":"Neurosurgery"},{"issue":"3","key":"4023_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3171\/2016.9.PEDS16161","volume":"19","author":"A Storey","year":"2017","unstructured":"Storey A, Scott RM, Robertson R, Smith E (2017) Preoperative transdural collateral vessels in Moyamoya as radiographic biomarkers of disease. J Neurosurg Pediatr 19(3):289\u2013295. https:\/\/doi.org\/10.3171\/2016.9.PEDS16161","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"4023_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2176\/nmc.oa.2014-0360","volume":"55","author":"T Funaki","year":"2015","unstructured":"Funaki T, Fushimi Y, Takahashi JC, Takagi Y, Araki Y, Yoshida K, Kikuchi T, Miyamoto S (2015) Visualization of periventricular collaterals in Moyamoya disease with flow-sensitive black-blood magnetic resonance angiography: preliminary experience. Neurol Med Chir (Tokyo) 55(3):204\u2013209. https:\/\/doi.org\/10.2176\/nmc.oa.2014-0360","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"6","key":"4023_CR17","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3171\/2015.6.JNS15845","volume":"124","author":"T Funaki","year":"2016","unstructured":"Funaki T, Takahashi JC, Yoshida K, Takagi Y, Fushimi Y, Kikuchi T, Mineharu Y, Okada T, Morimoto T, Miyamoto S (2016) Periventricular anastomosis in Moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg 124(6):1766\u20131772. https:\/\/doi.org\/10.3171\/2015.6.JNS15845","journal-title":"J Neurosurg"},{"issue":"3","key":"4023_CR18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3171\/2017.9.JNS172231","volume":"130","author":"S Yamamoto","year":"2019","unstructured":"Yamamoto S, Hori S, Kashiwazaki D, Akioka N, Kuwayama N, Kuroda S (2019) Longitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset. J Neurosurg 130(3):884\u2013890. https:\/\/doi.org\/10.3171\/2017.9.JNS172231","journal-title":"J Neurosurg"},{"issue":"6","key":"4023_CR19","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3171\/jns.1984.61.6.1032","volume":"61","author":"S Miyamoto","year":"1984","unstructured":"Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Ikota T, Takeuchi S (1984) Delayed cerebral blood supply through the leptomeningeal anastomosis in children with Moyamoya disease. J Neurosurg 61(6):1032\u20131037","journal-title":"J Neurosurg"},{"issue":"5","key":"4023_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3171\/2017.9.JNS172231","volume":"103","author":"N Kusaka","year":"2005","unstructured":"Kusaka N, Sugiu K, Tokunaga K, Katsumata A, Nishida A, Namba K, Hamada H, Nakashima H, Date I (2005) Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery. J Neurosurg 103(5):882\u2013890. https:\/\/doi.org\/10.3171\/2017.9.JNS172231","journal-title":"J Neurosurg"},{"key":"4023_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.brainres.2015.03.006","volume":"1623","author":"Y Nishijima","year":"2015","unstructured":"Nishijima Y, Akamatsu Y, Weinstein PR, Liu J (2015) Collaterals: implications in cerebral ischemic diseases and therapeutic interventions. Brain Res 1623:18\u201329. https:\/\/doi.org\/10.1016\/j.brainres.2015.03.006","journal-title":"Brain Res"},{"issue":"3","key":"4023_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.brainres.2015.03.006","volume":"3","author":"M Lim","year":"2006","unstructured":"Lim M, Cheshier S, Steinberg GK (2006) New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Curr Neurovasc Res 3(3):237\u2013245. https:\/\/doi.org\/10.1016\/j.brainres.2015.03.006","journal-title":"Curr Neurovasc Res"},{"issue":"4","key":"4023_CR23","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000121249","volume":"27","author":"AM Malek","year":"1997","unstructured":"Malek AM, Connors S, Robertson RL, Folkman J, Scott RM (1997) Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in Moyamoya and central nervous system disorders. Pediatr Neurosurg 27(4):182\u2013189. https:\/\/doi.org\/10.1159\/000121249","journal-title":"Pediatr Neurosurg"},{"issue":"1","key":"4023_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s10143-025-03544-8","volume":"48","author":"H Uchino","year":"2025","unstructured":"Uchino H, Ito M, Kurisu K, Sugiyama T, Fujimura M (2025) Association between intracranial vascular vulnerability and indirect revascularization development in Moyamoya disease. Neurosurg Rev 48(1):387. https:\/\/doi.org\/10.1007\/s10143-025-03544-8","journal-title":"Neurosurg Rev"},{"issue":"10","key":"4023_CR25","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3174\/ajnr.A6217","volume":"40","author":"X Lv","year":"2019","unstructured":"Lv X (2019) Hemorrhagic factors of Moyamoya disease. AJNR Am J Neuroradiol 40(10):1672\u20131673. https:\/\/doi.org\/10.3174\/ajnr.A6217","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"4023_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2176\/jns-nmc.2025-0112","volume":"65","author":"H Uchino","year":"2025","unstructured":"Uchino H, Ito M, Fujimura M (2025) Incidence and clinical characteristics of Moyamoya disease in advanced Suzuki disease stages. Neurol Med Chir (Tokyo) 65(9):389\u2013395. https:\/\/doi.org\/10.2176\/jns-nmc.2025-0112","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"4023_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.687088","volume":"12","author":"Y Mineharu","year":"2021","unstructured":"Mineharu Y, Miyamoto S (2021) RNF213 and GUCY1A3 in Moyamoya disease: key regulators of metabolism, inflammation, and vascular stability. Front Neurol 12:687088. https:\/\/doi.org\/10.3389\/fneur.2021.687088","journal-title":"Front Neurol"},{"issue":"1","key":"4023_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10143-007-0102-8","volume":"31","author":"S Sakamoto","year":"2008","unstructured":"Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, Shrestha P, Sugiyama K, Kurisu K (2008) Expression of vascular endothelial growth factor in dura mater of patients with moyamoya disease. Neurosurg Rev 31(1):77\u201381. https:\/\/doi.org\/10.1007\/s10143-007-0102-8","journal-title":"Neurosurg Rev"},{"issue":"10","key":"4023_CR29","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/sj.onc.1206226","volume":"22","author":"LH Wei","year":"2003","unstructured":"Wei LH, Kuo ML, Chen CA, Chou CH, Lai KB, Lee CN, Hsieh CY (2003) Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 22(10):1517\u20131527. https:\/\/doi.org\/10.1038\/sj.onc.1206226","journal-title":"Oncogene"},{"issue":"6","key":"4023_CR30","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/ijc.22006","volume":"119","author":"Y Adachi","year":"2006","unstructured":"Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel T, Nishimoto N (2006) Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int J Cancer 119(6):1303\u20131311. https:\/\/doi.org\/10.1002\/ijc.22006","journal-title":"Int J Cancer"},{"issue":"13","key":"4023_CR31","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1038\/sj.onc.1205260","volume":"21","author":"G Niu","year":"2002","unstructured":"Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21(13):2000\u20132008. https:\/\/doi.org\/10.1038\/sj.onc.1205260","journal-title":"Oncogene"},{"issue":"2","key":"4023_CR32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s10143-025-03544-8","volume":"121","author":"K Kazumata","year":"2014","unstructured":"Kazumata K, Ito M, Tokairin K, Ito Y, Houkin K, Nakayama N, Kuroda S, Ishikawa T, Kamiyama H (2014) The frequency of postoperative stroke in Moyamoya disease following combined revascularization: a single-university series and systematic review. J Neurosurg 121(2):432\u2013440. https:\/\/doi.org\/10.1007\/s10143-025-03544-8","journal-title":"J Neurosurg"},{"key":"4023_CR33","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1016\/j.wneu.2022.06.067","volume":"165","author":"T Okuyama","year":"2022","unstructured":"Okuyama T, Kawabori M, Ito M, Sugiyama T, Kazumata K, Fujimura M (2022) Outcomes of combined revascularization surgery for Moyamoya disease without preoperative cerebral angiography. World Neurosurg 165:e446\u2013e451. https:\/\/doi.org\/10.1016\/j.wneu.2022.06.067","journal-title":"World Neurosurg"},{"issue":"3","key":"4023_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.2176\/jns-nmc.2023-0219","volume":"64","author":"K Kurisu","year":"2024","unstructured":"Kurisu K, Ito M, Uchino H, Sugiyama T, Fujimura M (2024) Long-term outcomes of combined revascularization surgery for Moyamoya disease in the elderly: a single institute experience. Neurol Med Chir (Tokyo) 64(3):108\u2013115. https:\/\/doi.org\/10.2176\/jns-nmc.2023-0219","journal-title":"Neurol Med Chir (Tokyo)"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04023-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-04023-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-04023-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T07:11:41Z","timestamp":1766041901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-04023-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4023"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-04023-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7226764\/v1","asserted-by":"object"}]},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"27 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board in our institutes (approval number: 023\u20130359, approval date: May 28, 2024, at Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital and approval number: 06\/BNBO\/2023, approval date: November 8, 2023, at Bioethics Committee of the Lower Silesian Medical Chamber). This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants or the legal guardians of patients aged\u2009<\u200918\u00a0years.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}